Histogen Inc (HSTO)
0.17
-0.03
(-15.42%)
USD |
OTCM |
May 20, 15:38
Histogen Enterprise Value: -4.708M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | -4.708M |
| May 16, 2024 | -4.746M |
| May 15, 2024 | -4.751M |
| May 14, 2024 | -4.751M |
| May 13, 2024 | -4.751M |
| May 10, 2024 | -4.751M |
| May 09, 2024 | -4.751M |
| May 08, 2024 | -4.751M |
| May 07, 2024 | -4.922M |
| May 06, 2024 | -4.964M |
| May 03, 2024 | -4.964M |
| May 02, 2024 | -4.751M |
| May 01, 2024 | -4.751M |
| April 30, 2024 | -4.105M |
| April 29, 2024 | -4.105M |
| April 26, 2024 | -4.106M |
| April 25, 2024 | -4.109M |
| April 24, 2024 | -4.109M |
| April 23, 2024 | -4.110M |
| April 22, 2024 | -4.110M |
| April 19, 2024 | -4.964M |
| April 18, 2024 | -3.469M |
| April 17, 2024 | -3.469M |
| April 16, 2024 | -3.469M |
| April 15, 2024 | -3.469M |
| Date | Value |
|---|---|
| April 12, 2024 | -3.469M |
| April 11, 2024 | -3.469M |
| April 10, 2024 | -3.469M |
| April 09, 2024 | -3.469M |
| April 08, 2024 | -3.469M |
| April 05, 2024 | -3.469M |
| April 04, 2024 | -3.469M |
| April 03, 2024 | -3.469M |
| April 02, 2024 | -3.469M |
| April 01, 2024 | -4.067M |
| March 28, 2024 | -4.067M |
| March 27, 2024 | -3.896M |
| March 26, 2024 | -3.896M |
| March 25, 2024 | -3.939M |
| March 22, 2024 | -4.217M |
| March 21, 2024 | -3.896M |
| March 20, 2024 | -4.195M |
| March 19, 2024 | -4.195M |
| March 18, 2024 | -4.195M |
| March 15, 2024 | -4.195M |
| March 14, 2024 | -4.195M |
| March 13, 2024 | -3.939M |
| March 12, 2024 | -3.939M |
| March 11, 2024 | -4.110M |
| March 08, 2024 | -4.195M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-13.50M
Minimum
Jun 14 2022
55.16M
Maximum
Jun 09 2020
2.898M
Average
-4.195M
Median
Oct 24 2023
Enterprise Value Benchmarks
| CEL-SCI Corp | 63.47M |
| AIM ImmunoTech Inc | 7.729M |
| IGC Pharma Inc | 34.45M |
| NovaBay Pharmaceuticals Inc | 5.156M |
| Protalix BioTherapeutics Inc | 55.51M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.851M |
| Revenue (Quarterly) | 0.005M |
| Total Expenses (Quarterly) | 3.53M |
| EPS Diluted (Quarterly) | -0.90 |
| Profit Margin (Quarterly) | -77.02K% |
| Earnings Yield | -1.65K% |
| Normalized Earnings Yield | -1608.33 |